BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Yurtsever Z, Patel DA, Kober DL, Su A, Miller CA, Romero AG, Holtzman MJ, Brett TJ. First comprehensive structural and biophysical analysis of MAPK13 inhibitors targeting DFG-in and DFG-out binding modes. Biochim Biophys Acta 2016;1860:2335-44. [PMID: 27369736 DOI: 10.1016/j.bbagen.2016.06.023] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
Number Citing Articles
1 Yao T, Xiao H, Wang H, Xu X. Recent Advances in PROTACs for Drug Targeted Protein Research. IJMS 2022;23:10328. [DOI: 10.3390/ijms231810328] [Reference Citation Analysis]
2 Malekinejad Z, Baghbanzadeh A, Nakhlband A, Baradaran B, Jafari S, Bagheri Y, Raei F, Montazersaheb S, Farahzadi R. Recent clinical findings on the role of kinase inhibitors in COVID-19 management. Life Sci 2022;306:120809. [PMID: 35841979 DOI: 10.1016/j.lfs.2022.120809] [Reference Citation Analysis]
3 Liu R, Verma N, Henderson JA, Zhan S, Shen J. Profiling MAP kinase cysteines for targeted covalent inhibitor design. RSC Med Chem 2022;13:54-63. [DOI: 10.1039/d1md00277e] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
4 García-Hernández L, García-Ortega MB, Ruiz-Alcalá G, Carrillo E, Marchal JA, García MÁ. The p38 MAPK Components and Modulators as Biomarkers and Molecular Targets in Cancer. Int J Mol Sci 2021;23:370. [PMID: 35008796 DOI: 10.3390/ijms23010370] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
5 Chen J, Wang W, Sun H, Pang L, Bao H. Binding mechanism of inhibitors to p38α MAP kinase deciphered by using multiple replica Gaussian accelerated molecular dynamics and calculations of binding free energies. Comput Biol Med 2021;134:104485. [PMID: 33993013 DOI: 10.1016/j.compbiomed.2021.104485] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 12.0] [Reference Citation Analysis]
6 Anton DB, Ducati RG, Timmers LFSM, Laufer S, Goettert MI. A Special View of What Was Almost Forgotten: p38δ MAPK. Cancers (Basel) 2021;13:2077. [PMID: 33923030 DOI: 10.3390/cancers13092077] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
7 Liu Y, Chang Y, Cai Y. circTNFRSF21, a newly identified circular RNA promotes endometrial carcinoma pathogenesis through regulating miR-1227-MAPK13/ATF2 axis. Aging (Albany NY) 2020;12:6774-92. [PMID: 32299063 DOI: 10.18632/aging.103037] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 6.5] [Reference Citation Analysis]
8 Smith BE, Wang SL, Jaime-Figueroa S, Harbin A, Wang J, Hamman BD, Crews CM. Differential PROTAC substrate specificity dictated by orientation of recruited E3 ligase. Nat Commun 2019;10:131. [PMID: 30631068 DOI: 10.1038/s41467-018-08027-7] [Cited by in Crossref: 204] [Cited by in F6Publishing: 217] [Article Influence: 68.0] [Reference Citation Analysis]
9 Wang C, Steiner U, Sepe A. Synchrotron Big Data Science. Small 2018;14:1802291. [DOI: 10.1002/smll.201802291] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 5.3] [Reference Citation Analysis]
10 Cuenda A, Sanz-Ezquerro JJ. p38γ and p38δ: From Spectators to Key Physiological Players. Trends Biochem Sci 2017;42:431-42. [PMID: 28473179 DOI: 10.1016/j.tibs.2017.02.008] [Cited by in Crossref: 42] [Cited by in F6Publishing: 45] [Article Influence: 8.4] [Reference Citation Analysis]
11 Abbott JA, Livingston NM, Egri SB, Guth E, Francklyn CS. Characterization of aminoacyl-tRNA synthetase stability and substrate interaction by differential scanning fluorimetry. Methods 2017;113:64-71. [PMID: 27794454 DOI: 10.1016/j.ymeth.2016.10.013] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]